We are live on ! Find out more
PHVS icon

Pharvaris
PHVS

60 hedge funds and large institutions have $793M invested in Pharvaris in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

15% more funds holding

Funds holding: 52 → 60 (+8)

12% more capital invested

Capital invested by funds: $706M → $793M (+$87.2M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

0.55% less ownership

Funds ownership: 83.21% → 82.66% (-0.55%)

Holders
60
Holders Change
+8
Holders Change %
+15.38%
% of All Funds
0.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
19
Reduced
16
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
+$17.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.92M
3
TAM
TFG Asset Management
Cayman Islands
+$984K
4
ACM
ADAR1 Capital Management
Texas
+$550K
5
Citadel Advisors
Citadel Advisors
Florida
+$471K

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$17.2M
2
OCA
Octagon Capital Advisors
New York
-$1.57M
3
SCM
Soleus Capital Management
Connecticut
-$1.32M
4
SFM
Sphera Funds Management
Israel
-$1.19M
5
Morgan Stanley
Morgan Stanley
New York
-$251K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$1.65M -$1.79K -111 -0.1%
Morgan Stanley
27
Morgan Stanley
New York
$1.05M -$251K -15,593 -21%
UBS AM
28
UBS AM
Illinois
$975K -$209K -12,954 -19%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$952K +$254K +15,769 +41%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$860K +$127K +7,879 +19%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$662K -$241K -14,962 -28%
ACM
32
ADAR1 Capital Management
Texas
$601K +$550K +34,124 New
AA
33
ALPS Advisors
Colorado
$517K -$117K -7,235 -20%
Citadel Advisors
34
Citadel Advisors
Florida
$514K +$471K +29,221 New
Deutsche Bank
35
Deutsche Bank
Germany
$496K +$193 +12 +0%
Amundi
36
Amundi
France
$489K +$442K +27,416 +2,741,600%
Swiss National Bank
37
Swiss National Bank
Switzerland
$462K – – –
HS
38
HighVista Strategies
Massachusetts
$418K +$15.6K +971 +4%
BFM
39
Boothbay Fund Management
New York
$285K +$261K +16,187 New
Bank of America
40
Bank of America
North Carolina
$282K -$212K -13,183 -45%
PWM
41
Palumbo Wealth Management
New York
$256K +$7.2K +447 +3%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$247K +$20.3K +1,257 +10%
Millennium Management
43
Millennium Management
New York
$234K +$214K +13,285 New
Legal & General Group
44
Legal & General Group
United Kingdom
$203K +$27.3K +1,695 +17%
KK
45
KLP Kapitalforvaltning
Norway
$102K – – –
VIA
46
Virtus Investment Advisers
Connecticut
$96K -$51.2K -3,179 -37%
Ohio Public Employees Retirement System (OPERS)
47
Ohio Public Employees Retirement System (OPERS)
Ohio
$79.2K – – –
UBS Group
48
UBS Group
Switzerland
$65.9K -$59.7K -3,706 -50%
JP Morgan Chase
49
JP Morgan Chase
New York
$58.8K +$12.6K +783 +31%
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
$57K +$52.5K +3,261 New
1
2
3

PHVS Hedge Fund Activity: Q2 2025 in Review

60 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2025, worth a combined $793M — up 12% from $706M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PHVS positions and 1 closed out — a net gain of 8 holders — while 19 added to existing stakes and 16 trimmed.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $17.1M. The largest seller was VR Adviser, cutting an estimated $17.2M.

  • 60 institutional investors held Pharvaris (PHVS) as of Q2 2025, up from 52 in Q1 2025.
  • Funds reported $793M of Pharvaris stock for Q2 2025, up 12% quarter-over-quarter.
  • 9 funds opened new Pharvaris positions in Q2 2025 and 1 closed out, a net change of +8 holders.
  • The largest Pharvaris buyer in Q2 2025 was Paradigm Biocapital Advisors, an estimated $17.1M added.
  • The largest Pharvaris seller in Q2 2025 was VR Adviser, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2025.